R's third-quarter 2025 earnings reflect higher contractual earnings and share repurchases.

Ryder System, Inc. (NYSE:R ) Q3 2025 Earnings Call October 23, 2025 11:00 AM EDT Company Participants Calene Candela - Vice President of Investor Relations Robert Sanchez - Chairman & CEO Cristina Gallo-Aquino - CFO, EVP & Principal Accounting Officer John Diez - President & COO John Sensing - President of Global Supply Chain Solutions & Dedicated Transportation Solutions Tom Havens - President of Global Fleet Management Solutions Conference Call Participants Scott Group - Wolfe Research, LLC Ben Moore David Zazula - Barclays Bank PLC, Research Division Ravi Shanker - Morgan Stanley, Research Division Jeffrey Kauffman - Vertical Research Partners, LLC Jordan Alliger - Goldman Sachs Group, Inc., Research Division Harrison Bauer - Susquehanna Financial Group, LLLP, Research Division Brian Ossenbeck - JPMorgan Chase & Co, Research Division Presentation Operator Good morning and welcome to the Ryder System third Quarter 2025 Earnings Release Conference Call. [Operator Instructions] Today's call is being recorded.

The headline numbers for Ryder (R) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Combining peer-reviewed science, superior comfort, and thoughtful design, the Assisi Loop Lounge expands Zomedica's evidence-based therapeutic portfolio and reinforces Assisi's leadership in targeted tPEMF innovation ANN ARBOR, MI / ACCESS Newswire / October 23, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), an animal health company offering innovative point-of-care diagnostic and therapeutic products for equine and companion animals, today announced the launch of the Assisi Loop Lounge, a next-generation targeted pulsed electromagnetic field (tPEMF) therapy bed delivering full-body treatment and luxurious comfort for pets, now featuring unlimited uses and a lifetime warranty to provide lasting therapeutic value for pet owners and veterinary professionals alike. The Assisi Loop Lounge is the only small animal tPEMF device backed by peer-reviewed scientific research, making it the trusted choice of veterinarians and pet owners worldwide.

~Clearance expands Company's competitive advantage of clinically proven, minimally invasive technologies to treat debilitating SI joint conditions from multiple surgical approaches~ ~SImmetry+'s New 3D printed titanium implants, robust joint decorticator, and simple bone graft delivery system provides physicians treatment options rooted in established fusion principles~ ~Company initiating alpha launch of SImmetry® + with select group of physician users to provide initial feedback to support broader launch~ LOS GATOS, CA / ACCESS Newswire / October 21, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacro-pelvic disorders, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the SImmetry+ SI Joint Fusion System. The SImmetry+ System is indicated for sacroiliac (SI) joint fusion for conditions including sacroiliac joint disruptions and degenerative sacroiliitis, providing physicians with treatment options rooted in established fusion principles.

TORONTO, ON / ACCESS Newswire / October 17, 2025 / NextSource Materials Inc. (TSX:NEXT)(OTCQB:NSRCF) ("NextSource" or the "Company") wishes to confirm that operations at its Molo Graphite Mine in southern Madagascar and shipments of its SuperFlake® graphite concentrate remain unaffected by the current political situation in Madagascar. Mining and processing activities at the Molo mine continue under normal conditions, with the Company maintaining its regular campaign production and logistics schedules.

Live session on October 24th will showcase how the VETGuardian Monitor enhances patient care, improves workflow efficiency, and expands global market opportunities ANN ARBOR, MI / ACCESS Newswire / October 9, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), a veterinary health company offering innovative point-of-care diagnostic and therapeutic device products for equine and companion animals, today announced that its upcoming "Fourth Friday at Four" webinar series, to be held on October 24, 2025 at 4:00 p.m. ET, will feature a deep dive into Zomedica's VETGuardian Zero Touch monitoring platform.

R expands its Southeast footprint with a new facility in Lebanon, TN, boosting fleet support and service connectivity.

Toronto, Ontario--(Newsfile Corp. - September 26, 2025) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company"), a leader in needle-free subcutaneous drug-delivery technology, is pleased to announce that its exclusive UK distribution partner, EziAutoJector® Ltd, has received confirmation from the NHS Business Services Authority, on behalf of the Department of Health, that EziAutoJector® products have been approved for inclusion in the NHS Drug Tariff. This milestone provides for individuals with diabetes who are prescribed EziAutoJector® by their healthcare provider to receive the EziAutoJector® needle-free insulin delivery device and its accessories at no cost, as part of their NHS-funded diabetes care.

The consistent shareholder-friendly efforts of R to reward its shareholders through dividend hikes and share repurchases highlight its financial bliss.